BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36172677)

  • 21. Association of MDM2 and p53 polymorphisms with the advancement of cervical carcinoma.
    Singhal P; Hussain S; Thakur N; Batra S; Salhan S; Bhambani S; Bharadwaj M
    DNA Cell Biol; 2013 Jan; 32(1):19-27. PubMed ID: 23210739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between matrix metalloproteinase 2 and lung cancer progression.
    Guo CB; Wang S; Deng C; Zhang DL; Wang FL; Jin XQ
    Mol Diagn Ther; 2007; 11(3):183-92. PubMed ID: 17570740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. P53 and MDM2 co-expression in tobacco and betel chewing-associated oral squamous cell carcinomas.
    Shwe M; Chiguchi G; Yamada S; Nakajima T; Maung KK; Takagi M; Amagasa T; Tsuchida N
    J Med Dent Sci; 2001 Dec; 48(4):113-9. PubMed ID: 12160248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1-MMP, MMP-2 and MMP-9 in human glioblastomas.
    Munaut C; Noël A; Hougrand O; Foidart JM; Boniver J; Deprez M
    Int J Cancer; 2003 Oct; 106(6):848-55. PubMed ID: 12918061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of temozolomide on U87MG glioblastoma cell expression of CXCR4, MMP2, MMP9, VEGF, anti-proliferatory cytotoxic and apoptotic properties.
    Mirabdaly S; Elieh Ali Komi D; Shakiba Y; Moini A; Kiani A
    Mol Biol Rep; 2020 Feb; 47(2):1187-1197. PubMed ID: 31897867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
    Xiong J; Yang Q; Li J; Zhou S
    Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 gene mutations and expression of p53 and mdm2 proteins in invasive breast carcinoma. A comparative analysis with clinico-pathological factors.
    Günther T; Schneider-Stock R; Rys J; Niezabitowski A; Roessner A
    J Cancer Res Clin Oncol; 1997; 123(7):388-94. PubMed ID: 9260591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zoledronic acid inhibits proliferation and impairs migration and invasion through downregulating VEGF and MMPs expression in human nasopharyngeal carcinoma cells.
    Li XY; Lin YC; Huang WL; Hong CQ; Chen JY; You YJ; Li WB
    Med Oncol; 2012 Jun; 29(2):714-20. PubMed ID: 21431960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion.
    Pereza N; Ostojić S; Volk M; Kapović M; Peterlin B
    Reprod Biomed Online; 2012 May; 24(5):567-75. PubMed ID: 22406112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcoma.
    Kunz P; Sähr H; Lehner B; Fischer C; Seebach E; Fellenberg J
    BMC Cancer; 2016 Mar; 16():223. PubMed ID: 26979530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolite secretions of Lactobacillus plantarum YYC-3 may inhibit colon cancer cell metastasis by suppressing the VEGF-MMP2/9 signaling pathway.
    Yue YC; Yang BY; Lu J; Zhang SW; Liu L; Nassar K; Xu XX; Pang XY; Lv JP
    Microb Cell Fact; 2020 Nov; 19(1):213. PubMed ID: 33228670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of MMP2 and MMP9 gene polymorphisms with the recurrent spontaneous abortion: A meta-analysis.
    Yan Y; Fang L; Li Y; Yu Y; Li Y; Cheng JC; Sun YP
    Gene; 2021 Jan; 767():145173. PubMed ID: 33007375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of MDM2 SNP309 and p53 codon 72 polymorphisms on lung cancer risk and survival among non-smoking Chinese women in Singapore.
    Chua HW; Ng D; Choo S; Lum SS; Li H; Soh LY; Sabapathy K; Seow A
    BMC Cancer; 2010 Mar; 10():88. PubMed ID: 20219101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis.
    Wan Y; Wu W; Yin Z; Guan P; Zhou B
    BMC Cancer; 2011 May; 11():208. PubMed ID: 21619694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MDM2 overexpression with alteration of the p53 protein and gene status in oral carcinogenesis.
    Li XJ; Murai M; Koyama T; Wang DY; Hashimoto K
    Jpn J Cancer Res; 2000 May; 91(5):492-8. PubMed ID: 10835493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of MDM2-P2 transcripts correlates with stabilized wild-type p53 in betel- and tobacco-related human oral cancer.
    Ralhan R; Sandhya A; Meera M; Bohdan W; Nootan SK
    Am J Pathol; 2000 Aug; 157(2):587-96. PubMed ID: 10934161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MMP, VEGF and TIMP as prognostic factors in recurring bladder cancer.
    Wieczorek E; Jablonowski Z; Tomasik B; Konecki T; Jablonska E; Gromadzinska J; Fendler W; Sosnowski M; Wasowicz W; Reszka E
    Clin Biochem; 2015 Dec; 48(18):1235-40. PubMed ID: 26197083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.
    Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Suehiro Y; Tanaka Y; Dahiya R
    Clin Cancer Res; 2007 Jul; 13(14):4123-9. PubMed ID: 17634539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Pro allele of the p53 codon 72 polymorphism is associated with decreased intratumoral expression of BAX and p21, and increased breast cancer risk.
    Proestling K; Hebar A; Pruckner N; Marton E; Vinatzer U; Schreiber M
    PLoS One; 2012; 7(10):e47325. PubMed ID: 23071787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphisms of p53 and MDM2 genes are associated with severe toxicities in patients with non-small cell lung cancer.
    Zheng D; Chen Y; Gao C; Wei Y; Cao G; Lu N; Hou Y; Jiang X; Wang J
    Cancer Biol Ther; 2014; 15(11):1542-51. PubMed ID: 25482940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.